News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
DNAVEC, Chiba University, And Kyushu University To Form Research Consortium For Cancer Gene Therapy
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo (JCNN) - On April 13, DNAVEC, Chiba University and Kyushu University jointly announced the establishment of the CKD New Generation Cancer Gene Therapy Research Consortium, a research consortium for cancer gene therapy.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Deals
GSK bags Chimagen’s trispecific T cell engager in deal worth up to $750M
September 15, 2026
·
2 min read
·
Gabrielle Masson
Layoffs
GSK lays off 650 staffers amid closure of German vaccine manufacturing site
September 15, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
September 14, 2026
·
4 min read
·
Gabrielle Masson
C-suite
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
September 14, 2026
·
3 min read
·
Annalee Armstrong